Questions and Discussions on Alzheimers and Weight Loss Drugs Current Stage of Understanding Alzheimers & Weight Loss Drugs An observational study in more than 1 million patients with type 2 diabetes has found that weight loss medications, including the GLP-1 receptor agonist semaglutide (marketed as Ozempic and Wegovy) and the dual GLP-1/GIP agonist tirzepatide (marketed as Mounjaro and Zepbound), may have beneficial effects in Alzheimers disease
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, et al
In addition to discussing products to help reduce nausea from GLP-1s, we'll also cover the biggest mistakes people make that worsen the situation
How much weight did Kelly Clarkson lose
Cost and Insurance Step 3: Insurance and prior authorization If you have insurance, we'll check your benefits and submit a prior authorization for Wegovy, Zepbound, or whichever FDA-approved medication your provider prescribes